John M. Ringman, MD, MS

Professor of Clinical Neurology

Helene and Lou Galen Endowed Professorship in Neurology

Image of John M. Ringman, MD, MS
Is this your profile? Click to edit

Research Funding

  • Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
    NIH · U01NS100614 · Sep 30, 2021 – Jul 31, 2026 · Role: Co-Principal Investigator
  • Phenotype and Genotype of Autosomal Dominant Alzheimer's Disease in Jalisco, Mexico
    NIH · R01AG069013 · Sep 15, 2020 – May 31, 2025 · Role: Principal Investigator
  • Motor, Visual, and Olfactory Changes in Genetic Subtypes of Alzheimer?s Disease
    NIH · R01AG062007 · Feb 15, 2019 – Nov 30, 2024 · Role: Principal Investigator
  • Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
    NIH · UF1NS100614 · Sep 30, 2016 – Jul 31, 2023 · Role: Co-Principal Investigator
  • Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
    NIH · UH3NS100614 · Sep 30, 2016 – Jul 31, 2021 · Role: Co-Principal Investigator
  • Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
    NIH · UH2NS100614 · Sep 30, 2016 – Jul 31, 2018 · Role: Co-Principal Investigator
  • The structural and functional connectome across Alzheimer's disease subtypes
    NIH · U01AG051218 · Sep 30, 2015 – Jun 30, 2021 · Role: Principal Investigator
  • Establishing Infrastructure for Prevention of familial AD in Mexico
    NIH · R21TW009787 · Sep 1, 2013 – Apr 30, 2018 · Role: Principal Investigator
  • FMRI in Pre-Symptomatic PS1-related Alzheimer's Disease
    NIH · K08AG022228 · Aug 1, 2003 – Jul 31, 2007 · Role: Principal Investigator
  • UCLA Alzheimer's Disease Research Center
    NIH · P50AG016570 · Apr 5, 1999 – Mar 31, 2016 · Role: Co-Principal Investigator

Publications

  • Lower retinal capillary density in minimal cognitive impairment among older Latinx adults. Alzheimers Dement (Amst). 2020; 12(1):e12071.. View in PubMed
  • Cerebroarterial pulsatility and resistivity indices are associated with cognitive impairment and white matter hyperintensity in elderly subjects: A phase-contrast MRI study. J Cereb Blood Flow Metab. 2021 03; 41(3):670-683.. View in PubMed
  • APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020 05; 581(7806):71-76.. View in PubMed
  • A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid. Alzheimers Dement. 2020 06; 16(6):821-830.. View in PubMed
  • Probing Estrogen Sulfotransferase-Mediated Inflammation with [11C]-PiB in the Living Human Brain. J Alzheimers Dis. 2020; 73(3):1023-1033.. View in PubMed
  • Cognitive symptoms of Alzheimer’s disease: clinical management and prevention. BMJ. 2019 12 06; 367:l6217.. View in PubMed
  • Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):327-330.. View in PubMed
  • Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019 Sep; 51(9):1423-1424.. View in PubMed
  • Historical Migration revealed through a Case of Autosomal Dominant Alzheimer’s Disease. P R Health Sci J. 2019 09; 38(3):144-147.. View in PubMed
  • 1H MRS spectroscopy in preclinical autosomal dominant Alzheimer disease. Brain Imaging Behav. 2019 Aug; 13(4):925-932.. View in PubMed